Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Nora Vanegas-Arroyave MD

Nora Vanegas-Arroyave MD

Associate Professor of Neurology, Director of Neuromodulation Research, Parkinson’s Disease Center and Movement Disorders Center, Department of Neurology, Baylor College of Medicine, Houston, Texas

Dr. Vanegas is an Associate Professor of Neurology and Director of Neuromodulation Research at Baylor College of Medicine. She completed a combined clinical-research Movement Disorders fellowship with an emphasis on neuroimaging and neuromodulation, at the National Institutes of Health (NIH). Dr. Vanegas spent the first four years of her early career as a Movement Disorders Neurologist at Columbia University and transitioned to Baylor College of Medicine as Director of Neuromodulation Research for the Department of Neurology in 2020. Her clinical and research efforts focus on the use of neuromodulation therapies for the treatment of Parkinson's Disease. In addition, she has served as Principal Investigator for industry-sponsored clinical trials aiming to improve the diagnosis and treatment of patients with neurodegenerative conditions. As a bilingual neurologist (English and Spanish), the promotion of diversity in research participation is also one of her priorities. Dr. Vanegas has successfully mentored fellows and students in the development and execution of their research projects.


Dr. Vanegas has no relevant disclosures.